Welcome to our dedicated page for U S Physical Therapy SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
U.S. Physical Therapy, Inc. (USPH) files a range of reports with the U.S. Securities and Exchange Commission that document its operations as a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services. These SEC filings provide detail on its physical therapy operations segment, industrial injury prevention services, clinic additions and closures, financial performance, and capital allocation decisions.
On this Stock Titan page, investors can review U.S. Physical Therapy’s current reports on Form 8-K, which have recently covered topics such as acquisitions of multi-clinic physical therapy practices and management services companies, quarterly earnings results, dividend declarations, investor presentations, and research reports. For example, the company has filed 8-Ks describing acquisitions of a three-clinic physical therapy practice and a physical therapy management services company that manages a practice with eight clinic locations, as well as 8-Ks reporting results for specific quarters and announcing quarterly cash dividends.
In addition to 8-Ks, U.S. Physical Therapy files annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide segment information for physical therapy operations and industrial injury prevention services, along with discussions of revenue, operating costs, gross profit, and key operating metrics such as total patient visits and net rate per patient visit. These filings also include information about the company’s credit facilities, interest expense, and tax provisions.
Stock Titan enhances access to these documents by offering real-time updates from the SEC’s EDGAR system and AI-powered summaries that explain the contents of lengthy filings. Users can quickly see the main points from U.S. Physical Therapy’s 10-K and 10-Q reports, as well as key disclosures from 8-Ks related to acquisitions, earnings, and dividends. This page also serves as a starting point for reviewing any insider transaction reports on Form 4 that may be filed for USPH, alongside the company’s broader regulatory history.
U.S. Physical Therapy, Inc. Chief Financial Officer Carey P. Hendrickson reported an acquisition of 10,000 shares of common stock as a restricted stock grant. The award carried a zero dollar price per share and increased his directly held total to 37,808 shares.
The 10,000-share grant vests in 15 equal quarterly installments of 624 shares from May 20, 2026 through November 20, 2029, plus 640 shares vesting on March 6, 2030, under the company’s Amended and Restated 2003 Stock Incentive Plan.
US Physical Therapy Inc received an updated Schedule 13G/A showing institutional ownership as of 12/31/2025. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 1,212,494 US Physical Therapy Ord Shs, representing 8.0% of the class, with both sole and shared voting and dispositive powers.
Virtus Investment Advisers, LLC reports beneficial ownership of 731,069 shares, or 4.8%, all with shared voting and dispositive power. Virtus Equity Trust, on behalf of Virtus KAR Small-Cap Growth Fund, reports 667,088 shares, or 4.4%, with shared voting and dispositive power. The filers certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of US Physical Therapy.
U.S. Physical Therapy, Inc. reported two strategic moves. The company’s subsidiary partner, Metro Physical & Aquatic Therapy, entered a 10-year strategic alliance with NYU Langone Health to provide physical therapy services across Long Island and the New York metropolitan area.
On the same date, U.S. Physical Therapy announced it acquired a majority, 70% interest in an industrial injury prevention business for approximately $15.1 million, while the current owner retained 30%. The acquired business generates about $7.0 million in annual revenues, expanding U.S. Physical Therapy’s industrial injury prevention services portfolio.
Copeland Capital Management, LLC has filed a Schedule 13G reporting a passive ownership stake in U.S. Physical Therapy, Inc. common stock. The firm reports beneficial ownership of 786,114 shares, representing 5.17% of the outstanding common stock as of the event date.
Copeland Capital has sole voting power over 512,506 shares and shared voting power over 126,549 shares. It reports no sole dispositive power and shared dispositive power over all 786,114 shares. The securities are certified as being held in the ordinary course of business, not for the purpose of changing or influencing control of the company.
U.S. Physical Therapy, Inc. reported that it has acquired a 50% interest in a physical therapy management services company. This business exclusively manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and about 66,000 annual visits. The remaining 50% ownership is being retained by the current owners.
The transaction expands U.S. Physical Therapy’s presence in outpatient physical therapy and industrial injury prevention services by adding an established, revenue-generating group of clinics to its network.
U.S. Physical Therapy, Inc. (USPH) filed a Form 4 reporting an insider stock sale by its COO. On 11/24/2025, the reporting officer sold 743 shares of common stock in an open market transaction at a weighted average price of $71.01 per share, with individual trade prices ranging from $71.01 to $71.31.
After this transaction, the officer beneficially owns 20,740 shares directly and 1,808 shares indirectly through the Reeve Trust. The filing notes that 13,348 of these shares were granted as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan, with portions scheduled to vest in installments between March 2026 and March 2029, contingent on continued employment.
U.S. Physical Therapy, Inc. (USPH) director reported a purchase of company stock. On 11/20/2025, the reporting person bought 4,000 shares of common stock at a price of $69 per share, coded as a purchase transaction on a Form 4 filing. After this trade, the director beneficially owns 24,786 shares directly.
This total includes 471 restricted shares that were granted under the company’s Amended and Restated 2003 Stock Incentive Plan. These restricted shares will fully vest on March 6, 2026, provided she continues to serve on the Board of Directors through that date.
U.S. Physical Therapy (USPH) insider Graham Reeve has filed a Form 144 to sell 743 shares of common stock. The proposed sale has an aggregate market value of $52,761.58 and is planned for 11/21/2025 on the NYSE through J.P. Morgan Securities LLC. Shares outstanding were 15,204,119, providing context for the size of the planned sale. The shares to be sold relate to equity compensation, as 1,948 common shares were acquired on 11/21/2025 through the vesting of restricted stock grants issued between 08/16/2021 and 02/24/2025 as payment for services. In the prior three months, Reeve sold 763 common shares on 08/21/2025 for gross proceeds of $64,832.11. The signer represents that they are not aware of undisclosed material adverse information about the company’s operations.
U.S. Physical Therapy, Inc.
The updated presentation is being shared under a Regulation FD disclosure, meaning it is intended to provide fair and equal access to information for all investors. The materials are furnished rather than filed, so they are not automatically incorporated into other securities law filings unless specifically referenced.
U.S. Physical Therapy, Inc. furnished a conference call transcript as Exhibit 99.1 under Item 7.01 (Regulation FD). The call, held on November 6, 2025, discussed results for the three and nine months ended September 30, 2025.
The company states the information is furnished, not filed, is not subject to Section 18 of the Exchange Act, and will not be incorporated by reference into Securities Act or Exchange Act filings except as expressly set forth by specific reference.